Skip to main content
search
doug_lauffenburgerNews

Douglas Lauffenburger awarded the 2021 Gordon Prize

Congratulations to our Modeling Core Co-Lead, Dr. Douglas Lauffenburger, who recently received the 2021 Bernard M. Gordon Prize for Innovation in Engineering and Technology Education. The Gordon Prize is presented by the National Academy of Engineering (NAE) to award those who develop engineering leaders through new methods of education. As the Ford Professor of Bioengineering and the founding head of…
Michelle McGraw
December 19, 2021
News

CViSB Postdocs Travel to the DRC

Postdocs Raphaëlle Klitting and Edyth Parker were recently welcomed to the Pathogen Genomics Laboratory at the Institut National Recherche Biomédicale (INRB) in the Democratic Republic of the Congo (DRC) by CViSB collaborator, Dr. Placide Mbala. The purpose of the trip was two-fold; to sequence samples from the North Kivu Ebola outbreak 2018-2020 and to provide sequencing analysis workshops to INRB…
Michelle McGraw
October 4, 2021
Jobs

We are Hiring!

CViSB and Outbreak.info are HIRING! Do you have a passion for global health? An interest in infectious disease research such as Lassa Fever, Ebola, and SARS-CoV-2? Looking for an opportunity to work with leaders in the fields of computational biology, bioinformatics, and genomics?  We have positions open in a wide range of experience, backgrounds, and talents right now including: Backend…
Michelle McGraw
August 27, 2021
Publication

CViSB study shows how Mardi Gras 2020 accelerated Louisiana’s first COVID-19 wave

A CViSB-led study published in Cell outlines how the New Orleans’ Mardi Gras festival of February 2020 appears to have driven one of the worst early outbreaks of COVID-19 in the United States. Investigators sequenced and analyzed the COVID-19-causing coronavirus, SARS-CoV-2, recovered from patients, as well as data on population movements, COVID-19 deaths, and other relevant sources of information for…
Michelle McGraw
July 30, 2021
Publication

Investigation of a rare Ebola relapse case in Central Africa

A CViSB collaboration recently published their findings on an important Ebola relapse case in the Democratic Republic of Congo. A 25-year-old man who had been vaccinated against Ebola in December of 2018 fell ill with the disease six months later. He received experimental treatments for Ebola and was released from the hospital on June 29th, 2019. Unfortunately, the illness returned…
Michelle McGraw
May 6, 2021
MapPress Release

Launch of outbreak.info variant tracking

The Center for Viral Systems Biology (CViSB) at Scripps Research is tracking the prevalence of new variants of SARS-CoV-2—the virus behind the COVID-19 pandemic—and making this information publicly available to drive global research efforts. The daily situation reports appear on Outbreak.info, a website created by the same team in early 2020, shortly after the emergence of COVID-19. The new reports add to the website’s…
Kristian Andersen
February 17, 2021
NewsWorkshop

Symposium on Systems Biology of Host-Pathogen Interactions

We are pleased to announce the first Joint Symposium hosted by the Fluomics and CViSB centers. The symposium will highlight research from each center during eight brief talks. Keynote speaker Dr. Galit Alter from the Ragon Institute of MGH, MIT, and Harvard will give a talk on humoral immune system omics. The symposium will conclude with an open forum for…
Michelle McGraw
February 16, 2021
NewsPress Release

Scripps Research Tracks Prevalence of New COVID-19 Strains with Daily Situation Report

Feb. 10, 2021 LA JOLLA, CA – The Center for Viral Systems Biology (CViSB) at Scripps Research is tracking the prevalence of new strains of SARS-CoV-2, the virus behind the COVID-19 pandemic. The team behind Outbreak.info has created a dashboard for viewing daily reports that describe the current situation, focusing on the United States, and has made this publicly available…
Michelle McGraw
February 11, 2021
Publication

The emergence of SARS-CoV-2 in Europe and North America

Accurate understanding of the global spread of emerging viruses is critically important for public health responses and for anticipating and preventing future outbreaks. In a recent study published in Science, CViSB investigators and colleagues investigate when, where, and how the earliest sustained SARS-CoV-2 transmission networks became established in Europe and North America. The results suggest that rapid early interventions successfully…
Michelle McGraw
September 11, 2020
creidAwardsPress Release

NIAID funds new partner center

The ongoing COVID-19 pandemic has exposed the urgent need to protect the world from microbial threats, whenever and wherever they emerge. With a new $8.9 million grant, several CViSB investigators are partnering with peers in the United States and West Africa, a region of the world where infectious diseases are a high burden on public health. Together, we will seek…
Kristian Andersen
August 27, 2020
Close Menu